Tradestie Institutional Equity Comparison Engine
ACEP vs ECOR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ECOR Overall Edge
ECOR Captures Institutional Edge (1โ1 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to electroCore, Inc. Common Stock (ECOR) driven by superior Growth & Margin while ACEP counters with relative strength in Momentum & Technical. Fundamentally, ACEP trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ECOR at N/M Forward P/E and -33.1% operating margin (+11.5% YoY). In options structure, ACEP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ECOR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
ACEP N/M vs ECOR N/M Fwd P/E
Growth & Margin Winner
ECOR
Op Margin N/A vs -33.1% ยท YoY N/A vs +11.5%
Momentum & Technical Winner
ACEP
1Y +25.1% vs -4.0% ยท 52W Pos 65% vs 6%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ACEP
US Equity
ACEP
Institutional Equity
$18.92
-1.45% 1D
Market Cap
N/A
1M Return
-5.81%
1Y Return
+25.1%
Forward P/E
N/M
Unified AI Score
52.6 / 100
HOLD
Tech 51.0
Fund 51.0
Flow 50.0
Mom 70.0
ECOR
NASDAQ
electroCore, Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$4.85
-6.19% 1D
Market Cap
$47.7M
1M Return
-34.01%
1Y Return
-3.96%
Forward P/E
N/M
Unified AI Score
56.8 / 100
HOLD
Tech 68.0
Fund 53.0
Flow 50.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ACEP +25.1%
ECOR -3.96%
Spread: +22.13 pp (ACEP Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ACEP TTM Op. Margin: N/A
ECOR TTM Op. Margin: -33.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ACEP vs ECOR. Trailing 12-month operating profitability (ACEP N/A vs ECOR -33.1%) and valuation multiples (ACEP N/M vs ECOR N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ACEP | ECOR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $47.7M | Larger Scale | ECOR |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | +11.5% | Higher Growth | ECOR |
| Operating Margin (TTM) Profitability | N/A | -33.1% | Higher Margin | ECOR |
| Net Profit Margin Profitability | N/A | -33.5% | Higher Margin | ECOR |
| Return on Equity (ROE) Capital Efficiency | N/A | -478.7% | Higher ROE | ECOR |
| 52-Week Range Position Momentum | 65% ($15โ$21) | 6% ($4โ$13) | Stronger Trend | ACEP |
| Beta / 30D Volatility Risk Regime | 0.84ฮฒ ยท 20% Vol | 1.52ฮฒ ยท 155% Vol | Lower Realized Risk | ACEP |
| Unified Institutional Score Composite Signal | 52.6 / 100 (HOLD) | 56.8 / 100 (HOLD) | Higher Composite | ECOR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ACEP vs ECOR Buy Guide
ACEP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ECOR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ACEP nor ECOR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.